We present the molecular level studies on the aggregation mechanism of peptides relating to the biogenesisof various neurological disorder processes.The fine structural characteristics of amyloid peptides,as well asdetailed binding mechanisms of the drug molecules or labeling molecules with the amyloids,are keen to thepharmaceutical studies of drug molecules and pathological analysis at molecular level for neurodegenerativedisorder processes such as Alzheimers disease.